|
|
Workshop Discussions
Summary of questions appropriate
for discussion in the Workshop Session Defining the Problem(Surveillance
and Clinical Aspects)
- 1. Is this outline of Opportunities
for Effective Action a useful guide for the discussion in this Workshop
Session? What are some of the most significant ways in which it can
be improved?
2. From the Opportunity for Individuals/Employers/Supervisors/Insurers/Site
Owners to take effective action to maintain a safe and healthful site:
a. Are there effective educational materials intended to a lert individuals
to the potential for harm by exposing skin to chemicals? List at I.A.2.a
b. Are there surveillance, case report or other data suggesting certain
industries, occupations, tasks or chemicals for which a greater educational
effort is needed to alert individuals to potential hazards?>
3. From the Opportunity for Manufacturers/Distributors to take effective
actions to maintain product stewardship:
Considering II.D, is identifying opportunities to recycle products and
avoid introduction into the general environment via landfills an opportunity
to take effective action to reduce the burden of harmful exposures of
skin to chemicals?
4. From the Opportunity for Clinicians to take effective action to evaluate
and promote the health of individuals or populations:
a. Are there educational materials (List at III.A.2.a.i
) or Continuing
Medical Education courses (list at III.A.2.b.i
) to highlight for
clinicians that exposure of skin to chemicals can be harmful?
b. Are there relevant guidelines for receiving patients or recruiting
populations appropriate for general practitioners/primary care physicians
(List at III.B.1.a
), dermatologists (List at III.B.2.a
), occupational/environmental
physicians (List at III.B.3.a
), clinical epidemiologists (List at
III.B.4.a
), occupational nurses (List at III.B.5.a
) or other clinicians
(List at III.B.6.a
)?
c. Are there relevant guidelines for taking a health history with
an appropriate emphasis on occupational and environmental exposures?
(List at III.C.1.a
)
d. Are there relevant guidelines for conducting a physical exam? (List
at III.C.2.a
)
e. Are there guidelines for establishing an initial working diagnosis
for local skin effects (List at III.C.3.a.1
) or systemic toxicity
potentially caused by chemical exposures of the skin (List at III.C.3.b.1
)?
f. Are there guidelines for confirmatory testing for local skin effects
(List at III.C.4.a.1
) or systemic toxicity caused by chemical exposures
of the skin (List at III.C.4.b.1
)?
g. Are there guidelines for the role of confirmatory testing in determining
etiology (whether the condition is caused by chemical exposure of
the skin)? List at III.D.1
h. Are there guidelines for the role of return to work, return to
exposures and follow-up in determining etiology?
i. Is there information on how issues of resources (e.g., time), compensation,
and managed care directives influence investigative pursuits? List
at III.D.3.a
5. From the Opportunity for National or International Bodies to take
effective action by outlining technical requirements or recommendations:
a. Are there exposure databases that could be used to identify additional
circumstances in which harmful skin exposures may be occurring? List
at IV.A.1.a.i
b. Are there health effect databases that could be used to identify
additional circumstances in which harmful skin exposures may be occurring?
List at IV.A.1.b.i
6. Within the scope of this Workshop Session, what is the relative importance
of:
a. doing a better job of applying existing data using existing decision-making
procedures,
b. obtaining new data using accepted data-gathering protocols,
c. developing better data-gathering protocols and
d. developing better decision-making procedures
in order to improve the outputs from each step of an Opportunity for
Effective Action?
7. What research is likely to have the most impact on improving the
ability of various actors to take effective actions?
|
